Get the Stockscreener App
206.63
1.12%
2.29
Iqvia Holdings Inc stock is traded at $206.63, with a volume of 1.73M.
It is up +1.12% in the last 24 hours and up +11.92% over the past month.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
See More
Previous Close:
$204.34
Open:
$204.95
24h Volume:
1.73M
Relative Volume:
1.12
Market Cap:
$35.13B
Revenue:
$15.70B
Net Income/Loss:
$1.24B
P/E Ratio:
29.93
EPS:
6.9036
Net Cash Flow:
$2.01B
1W Performance:
+15.08%
1M Performance:
+11.92%
6M Performance:
+23.22%
1Y Performance:
-9.13%
1-Day Range:
$204.11
$209.48
1-Week Range:
$177.08
$209.48
52-Week Range:
$134.65
$237.34
Iqvia Holdings Inc Stock (IQV) Company Profile
Name
Iqvia Holdings Inc
Sector
Industry
Phone
919-998-2000
Address
2400 ELLIS ROAD, DURHAM, NC
Compare IQV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Upgrade | Jefferies | Hold → Buy |
| Apr-25-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-10-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Feb-03-25 | Downgrade | BTIG Research | Buy → Neutral |
| Dec-20-24 | Initiated | Stephens | Overweight |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-04-24 | Initiated | RBC Capital Mkts | Outperform |
| Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
| Jun-06-24 | Initiated | Goldman | Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-15-24 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-13-24 | Initiated | BTIG Research | Buy |
| Nov-02-23 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-06-23 | Initiated | HSBC Securities | Buy |
| Mar-17-23 | Initiated | Truist | Buy |
| Dec-06-22 | Initiated | Cowen | Outperform |
| Nov-17-22 | Downgrade | Citigroup | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-15-22 | Initiated | SVB Leerink | Outperform |
| May-24-22 | Initiated | Guggenheim | Buy |
| Apr-29-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Apr-16-21 | Upgrade | Stephens | Equal-Weight → Overweight |
| Mar-08-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jul-07-20 | Initiated | Stephens | Equal-Weight |
| Mar-02-20 | Initiated | Deutsche Bank | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Dec-13-19 | Upgrade | CFRA | Sell → Hold |
| Nov-14-19 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-21-19 | Upgrade | Mizuho | Neutral → Buy |
| May-28-19 | Initiated | SVB Leerink | Outperform |
| Jan-18-19 | Upgrade | Jefferies | Hold → Buy |
| Oct-09-18 | Initiated | UBS | Buy |
| Oct-02-18 | Reiterated | Robert W. Baird | Outperform |
| Jul-25-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-25-18 | Reiterated | Stifel | Buy |
| Jul-03-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Apr-13-18 | Upgrade | Goldman | Neutral → Buy |
| Mar-07-18 | Upgrade | SunTrust | Hold → Buy |
| Jan-19-18 | Initiated | Evercore ISI | Outperform |
View All
Iqvia Holdings Inc Stock (IQV) Latest News
What hedge fund moves indicate for IQVIA Holdings Inc. stockSell Signal & Community Consensus Trade Alerts - newser.com
Developing predictive dashboards with IQVIA Holdings Inc. dataWeekly Gains Summary & Step-by-Step Swing Trade Plans - newser.com
Relative strength of IQVIA Holdings Inc. in sector analysisPortfolio Return Summary & Safe Entry Momentum Tips - newser.com
Analyzing IQVIA Holdings Inc. with multi timeframe chartsTrade Performance Summary & AI Forecast for Swing Trade Picks - newser.com
Will IQVIA Holdings Inc. stock beat international competitionWeekly Trade Review & Risk Managed Investment Entry Signals - newser.com
What recovery options are there for IQVIA Holdings Inc.2025 Dividend Review & Real-Time Market Trend Scan - newser.com
Is IQVIA Holdings Inc. stock a safe haven assetMarket Performance Summary & AI Powered Market Trend Analysis - newser.com
Will IQVIA Holdings Inc. stock recover faster than peersJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
Barclays Maintains Rating and Raises Price Target for IQVIA (IQV) | IQV Stock News - GuruFocus
Barclays Adjusts Price Target on IQVIA Holdings Inc to $200 From $185, Maintains Equalweight Rating - MarketScreener
Why IQVIA (IQV) Stock Is Trading Up Today - Yahoo Finance
IQVIA Holdings Hits Day High with 7.5% Surge in Strong Intraday Performance - Markets Mojo
Will IQVIA Holdings Inc. stock benefit from infrastructure bill2025 Support & Resistance & Technical Confirmation Trade Alerts - newser.com
Real World Evidence Solutions Research and Forecast Report 2025-2030: Growth Opportunities in Emerging Markets and Increased Focus on End-To-End Rwe Services, & Personalized and Precision Medicine - GlobeNewswire Inc.
How to use a screener to detect IQVIA Holdings Inc. breakoutsWeekly Risk Report & Consistent Income Trade Recommendations - newser.com
IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025 - BioSpace
What Makes IQVIA (IQV) an Attractive Investment? - MSN
IQVIA Holdings Inc. (IQV) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Yahoo Finance
IQVIA Spikes: Is It a Rising Star? - StocksToTrade
Decoding the Sudden Surge in IQVIA Stock: A Close Look - timothysykes.com
Is IQVIA Holdings Inc a good long term investmentProtective Put Strategies & Free Fastest Return On Investment - earlytimes.in
Raleigh Capital Management Inc. Raises Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Is IQVIA Holdings Inc. stock in correction or buying zoneGap Up & Stepwise Entry and Exit Trade Signals - newser.com
Is it too late to sell IQVIA Holdings Inc.Jobs Report & Weekly Consistent Profit Watchlists - newser.com
What drives IQVIA Holdings Inc stock priceMomentum Stock Picks & Free Rapid Wealth Building - earlytimes.in
What high frequency data says about IQVIA Holdings Inc.Weekly Trade Report & Verified Chart Pattern Signals - newser.com
How IQVIA Holdings Inc. stock trades in high volatilityJuly 2025 Institutional & Long-Term Investment Growth Plans - newser.com
Patton Fund Management Inc. Acquires New Shares in IQVIA Holdings Inc. $IQV - MarketBeat
What Are Wall Street Analysts' Target Price for IQVIA Holdings Stock? - MSN
What analysts say about Vera Therapeutics Inc stockFibonacci Extensions & Small Budget Trading Plans - Early Times
Camelot Portfolios LLC Purchases Shares of 3,510 IQVIA Holdings Inc. $IQV - MarketBeat
Dakota Wealth Management Buys New Shares in IQVIA Holdings Inc. $IQV - MarketBeat
Voya Financial Advisors Inc. Purchases 5,321 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Howard Capital Management Group LLC Purchases 5,670 Shares of IQVIA Holdings Inc. $IQV - MarketBeat
Wealth Enhancement Advisory Services LLC Boosts Holdings in IQVIA Holdings Inc. $IQV - MarketBeat
Fifth Third Bancorp Grows Stake in IQVIA Holdings Inc. $IQV - MarketBeat
Iqvia Holdings Inc Stock (IQV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.12%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):